Scherz
Avigdor Scherz, Rehovot IL
Patent application number | Description | Published |
---|---|---|
20110064658 | RGD-(bacterio)chlorophyll conjugates for photodynamic therapy and Imaging of Necrotic tumors - RGD-chlorophyll and RGD-bacteriochlorophyll conjugates that home and accumulate in necrotic tumor domains much longer than in tumor non-necrotic domains are provided for use in minimally invasive tumor-targeted imaging, tumor-targeted photodynamic therapy, and/or on-line prognosis of necrotic tumors. | 03-17-2011 |
20110117029 | WATER-SOLUBLE ANIONIC BACTERIOCHLOROPHYLL DERIVATIVES AND THEIR USES - The invention provides anionic water-soluble tetracyclic and pentacyclic bacteriochlorophyll derivatives (Bchls) containing at least one, preferably two or three, negatively charged groups and/or acidic groups that are converted to negatively charged groups at the physiological pH, preferably Bchls having a group COO<−>, COS<−>, SO3<−>, PO3<2−>, COOH, COSH, SO3H, and/or PO3H2 bound through an ester or amide bond to one or more of the positions 17<3>, 13<3>, and 3<2> of the tetracyclic or pentacyclic Bchl molecule, for photodynamic therapy and diagnosis. | 05-19-2011 |
20120294801 | CONJUGATES OF RGD PEPTIDES AND PORPHYRIN OR (BACTERIO)CHLOROPHYLL PHOTOSYNTHESIZERS AND THEIR USES - Conjugates of porphyrin, chlorophyll and bacteriochlorophyll photosensitizers with RGD-containing peptides or RGD peptidomimetics are provided that are useful for photodynamic therapy (PDT), particularly vascular-targeted PDT (VTP), of tumors and nonneoplastic vascular diseases such as age-related macular degeneration, and for diagnosis of tumors by different techniques. | 11-22-2012 |
20130345417 | WATER SOLUBLE ANIONIC BACTERIOCHLOROPHYLL DERIVATIVES AND THEIR USES - The invention provides anionic water-soluble tetracyclic and pentacyclic bacteriochlorophyll derivatives (Bchls) containing at least one, preferably two or three, negatively charged groups and/or acidic groups that are converted to negatively charged groups at the physiological pH, preferably Bchls having a group COO<−>, COS<−>, SO3<−>, PO3<2−>, COOH, COSH, SO3H, and/or PO3H2 bound through an ester or amide bond to one or more of the positions 17<3>, 13<3>, and 3<2> of the tetracyclic or pentacyclic Bchl molecule, for photodynamic therapy and diagnosis. | 12-26-2013 |
20140088293 | PHOTOSYNTHETIC ORGANISMS AND COMPOSITIONS AND METHODS OF GENERATING SAME - An isolated polynucleotide is provided. The isolated polynucleotide comprising a nucleic acid sequence encoding a polypeptide of a Type II reaction center of a photosynthetic organism, the nucleic acid sequence being capable of imparting the type II reaction center with an activity under a temperature range different than that of the type II reaction center endogenous to the photosynthetic organism. Also provided are methods of using the sequences for generating photosynthetic organisms or tailor-made thermotolerance. | 03-27-2014 |
20140378888 | (BACTERIO)CHLOROPHYLL PHOTOSENSITIZERS FOR TREATMENT OF EYE DISEASES AND DISORDERS - An ophthalmic composition is provided, comprising chlorophyll or bacteriochlorophyll compounds for photodynamic treatment (PDT) of diseases, disorders and conditions associated with corneal or scleral anomalies such as corneal thinning and scleral stretching. | 12-25-2014 |
20150238773 | WATER SOLUBLE ANIONIC BACTERIOCHLOROPHYLL DERIVATIVES AND THEIR USES - The invention provides anionic water-soluble tetracyclic and pentacyclic bacteriochlorophyll derivatives (Bchls) containing at least one, preferably two or three, negatively charged groups and/or acidic groups that are converted to negatively charged groups at the physiological pH, preferably Bchls having a group COO<->, COS<->, SO3<->, PO3<2->, COOH, COSH, SO3H, and/or PO3H2 bound through an ester or amide bond to one or more of the positions 17<3>, 13<3>, and 3<2> of the tetracyclic or pentacyclic Bchl molecule, for photodynamic therapy and diagnosis. | 08-27-2015 |
Avigdor Scherz, Newe Amit IL
Patent application number | Description | Published |
---|---|---|
20110040170 | ENDOSCOPIC IMAGING PHOTODYNAMIC THERAPY SYSTEM AND METHODS OF USE - The invention provides an endoscopic imaging photodynamic therapy system (EIPS) for focused tissue ablation by illumination of a photosensitizer drug in a target tissue, said system comprising an endoscopic assembly, a real-time imaging component for locating the target tissue and monitoring the ablation intervention, a therapeutic light system and, optionally, a drug delivery module, wherein said imaging component comprises a flexible transducer with an operative channel for insertion of a flexible light guide of the therapeutic light system and, optionally, a flexible drug delivery catheter of the drug delivery module. This EIPS may be used in various medical applications where tissue ablation is required and photodynamic therapy may be applied, in particular, in the treatment of extrauterine pregnancy (EUP). | 02-17-2011 |
Avigdor Scherz, Rechovot IL
Patent application number | Description | Published |
---|---|---|
20080232156 | Method using a synthetic molecular spring device in a system for dynamically controlling a system property and a corresponding system thereof - Using a synthetic molecular spring device in a system for dynamically controlling a system property, such as momentum, topography, and electronic behavior. System features (a) the synthetic molecular spring device having (i) at least one synthetic molecular assembly each featuring at least one chemical unit including at least one: (1) atom; (2) complexing group complexed to at least one atom; (3) axial ligand reversibly physicochemically paired with at least one complexed atom; and (4) substantially elastic molecular linker; and, (ii) an activating mechanism directed to at least one atom-axial ligand pair; and, (b) a selected unit operatively coupled to synthetic molecular assembly, and exhibiting the system property. Activating mechanism sends an activating signal to atom-axial ligand pairs, for physicochemically modifying atom-axial ligand pairs, thereby activating at least one cycle of spring-type elastic reversible transitions between contracted and expanded linear conformational states of substantially elastic molecular linkers, causing dynamically controllable change in the system property. | 09-25-2008 |
20100031395 | PHOTOSYNTHETICORGANISMS AND COMPOSITIONS AND METHODS OF GENERATING SAME - An isolated polynucleotide is provided. The isolated polynucleotide comprising a nucleic acid sequence encoding a polypeptide of a Type II reaction center of a photosynthetic organism, the nucleic acid sequence being capable of imparting the type II reaction center with an activity under a temperature range different than that of the type II reaction center endogenous to the photosynthetic organism. Also provided are methods of using the sequences for generating photosynthetic organisms or tailor-made thermotolerance. | 02-04-2010 |
Cynthia Scherz, Allaman CH
Patent application number | Description | Published |
---|---|---|
20160001970 | Packs for Preparing Beverages - A pack in which a food or beverage ingredient is stored and in which a beverage is produced when water is introduced inside is disclosed, along with methods of production and use thereof. | 01-07-2016 |
Johannes Scherz, Wundschuh AT
Patent application number | Description | Published |
---|---|---|
20080319141 | Urethane Modified Water-Reducible Alkyd Resins - Urethane modified water-reducible alkyd resins ABCD, comprising moieties derived from polyhydric alcohols A, modified fatty acids B made hγ grafting olefinically unsaturated carboxylic acids B2 onto fatty acids B1, ungrafted fatty acids C and polyfunctional isocyanates D, a process for their production, and a method of use thereof in coating binders | 12-25-2008 |
20100174035 | POLYSILOXANE AND URETHANE MODIFIED WATER-REDUCIBLE ALKYD RESINS - Urethane and siloxane modified water-reducible alkyd resins ABCDE, comprising moieties derived from polyhydric alcohols A, modified fatty acids B made by grafting olefinically unsaturated carboxylic acids B2 onto fatty acids B1, ungrafted fatty acids C, silanol or alkoxysilyl functional siloxane oligomers or polymers D, and polyfunctional isocyanates E, a process for their production, and a method of use thereof in coating binders. | 07-08-2010 |
Michael Scherz, Oberwil CH
Patent application number | Description | Published |
---|---|---|
20140315964 | DOSING REGIMEN FOR A SELECTIVE S1P1 RECEPTOR AGONIST - The present invention relates to a dosing regimen for a selective S1P | 10-23-2014 |
20140316140 | DOSING REGIMEN FOR A SELECTIVE S1P1 AGONIST - The present invention relates to a dosing regimen for a selective S1P | 10-23-2014 |
20150265580 | DOSING REGIMEN FOR A SELECTIVE S1P1 RECEPTOR AGONIST - The present invention relates to a dosing regimen for a selective S1P | 09-24-2015 |
Michael Scherz, Ettingen CH
Patent application number | Description | Published |
---|---|---|
20080280962 | NOVEL THIAZOLIDIN-4-ONE DERIVATIVES - The invention relates to pharmaceutical compositions containing at least one thiazolidin-4-one derivative to prevent or treat disorders associated with an activated immune system. Furthermore, the invention relates to novel thiazolidin-4-one derivatives notably for use as pharmaceutically active compounds. Said compounds particularly act also as immunosuppressive agents. | 11-13-2008 |
20090275625 | NOVEL THIAZOLIDIN 4-ONE DERIVATIVES - The invention relates to pharmaceutical compositions containing at least one thiazolidin-4-one derivative to prevent or treat disorders associated with an activated immune system. Furthermore, the invention relates to novel thiazolidin-4-one derivatives notably for use as pharmaceutically active compounds. Said compounds particularly act also as immunosuppressive agents. | 11-05-2009 |
20110021581 | DOSING REGIMEN FOR A SELECTIVE S1P1 RECEPTOR AGONIST - The present invention relates to a dosing regimen for a selective S1P | 01-27-2011 |
20120302612 | NOVEL THIAZOLIDIN-4-ONE DERIVATIVES - The invention relates to pharmaceutical compositions containing at least one thiazolidin-4-one derivative to prevent or treat disorders associated with an activated immune system. Furthermore, the invention relates to novel thiazolidin-4-one derivatives notably for use as pharmaceutically active compounds. Said compounds particularly act also as immunosuppressive agents. | 11-29-2012 |
20130310432 | NOVEL THIAZOLIDIN-4-ONE-DERIVATIVES - The invention relates to pharmaceutical compositions containing at least one thiazolidin-4-one derivative to prevent or treat disorders associated with an activated immune system. Furthermore, the invention relates to novel thiazolidin-4-one derivatives notably for use as pharmaceutically active compounds. Said compounds particularly act also as immunosuppressive agents. | 11-21-2013 |
20140303217 | DOSING REGIMEN FOR A SELECTIVE S1P1 RECEPTOR AGONIST - The present invention relates to a dosing regimen for a selective S1P | 10-09-2014 |
Peter A. Scherz, Orange, CA US
Patent application number | Description | Published |
---|---|---|
20110197415 | COMESTIBLE PRODUCT SHEETER WITH REAR ACCESS - A comestible product sheeter is configured to provide enhanced access to the rollers and other components of the roller assembly. The one or more frame members of the roller assembly are configured to support the rollers at different vertical locations. Enhanced access is provided to both the rear and front rollers of the roller assembly by supporting one of the rollers in a cantilever configuration. The roller assembly may also be provided with a pivotally mounted cutting roller support arm to further improve access to the rollers and other components of the roller assembly. | 08-18-2011 |
Peter A. Scherz, La Habra, CA US
Patent application number | Description | Published |
---|---|---|
20120225151 | SHEETER WITH THICKNESS CONTROL - A thickness control system for a high speed tortilla sheeting machine can adjust a pinch point gap between a pair of sheeting rollers to maintain a generally uniform thickness of the produced “masa” (i.e., corn dough) sheet. The sheeting machine can include a pinch point gap adjustment device which guides at least one of the rollers through an arcuate path to thereby adjust a magnitude of the pinch point gap. The controller can direct one or more actuators to change the position of the roller along the archive path to thereby change the distance between the two sheeting rollers as desired to produce a masa sheet at the desired preset thickness. | 09-06-2012 |
20150110938 | SHEETER WITH THICKNESS CONTROL - A thickness control system for a high speed tortilla sheeting machine can adjust a pinch point gap between a pair of sheeting rollers to maintain a generally uniform thickness of the produced “masa” (i.e., corn dough) sheet. The sheeting machine can include a pinch point gap adjustment device which guides at least one of the rollers through an arcuate path to thereby adjust a magnitude of the pinch point gap. The controller can direct one or more actuators to change the position of the roller along the archive path to thereby change the distance between the two sheeting rollers as desired to produce a masa sheet at the desired preset thickness. | 04-23-2015 |